Japan Panel OKs J&J Coronavirus Vaccine
Newsfrom JapanSociety Health
Tokyo, May 30 (Jiji Press)--A panel of Japan's health ministry Monday endorsed a ministry plan to give pharmaceutical approval to U.S. drugmaker Johnson & Johnson's COVID-19 vaccine.
The ministry is expected to grant the approval soon to what will be the fifth COVID-19 vaccine that can be used in the country.
The ministry does not plan to make inoculations of the vaccine free of charge at public expense because it has already secured necessary amounts of vaccines. Japan has not signed to buy the J&J vaccine.
The J&J product is a viral vector vaccine like the one made by British drugmaker AstraZeneca PLC. It can be administered only to people aged 18 or above.
Only a single shot is necessary for the J&J vaccine unlike the previously approved vaccines, all of which require two shots at an interval of at least three to four weeks.
[Copyright The Jiji Press, Ltd.]